Literature DB >> 19153083

MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization.

Dong Meng1, Martin J Lynch, Elaine Huston, Michael Beyermann, Jenny Eichhorst, David R Adams, Enno Klussmann, Enno Klusmann, Miles D Houslay, George S Baillie.   

Abstract

betaArrestin is a multifunctional signal scaffold protein. Using SPOT immobilized peptide arrays, coupled with scanning alanine substitution and mutagenesis, we show that the MAPK kinase, MEK1, interacts directly with betaarrestin1. Asp(26) and Asp(29) in the N-terminal domain of betaarrestin1 are critical for its binding to MEK1, whereas Arg(47) and Arg(49) in the N-terminal domain of MEK1 are critical for its binding to betaarrestin1. Wild-type FLAG-tagged betaarrestin1 co-immunopurifies with MEK1 in HEKB2 cells, whereas the D26A/D29A mutant does not. ERK-dependent phosphorylation at Ser(412) was compromised in the D26A/D29A-betaarrestin1 mutant. A cell-permeable, 25-mer N-stearoylated betaarrestin1 peptide that encompassed the N-domain MEK1 binding site blocked betaarrestin1/MEK1 association in HEK cells and recapitulated the altered phenotype seen with the D26A/D29A-betaarrestin1 in compromising the ERK-dependent phosphorylation of betaarrestin1. In addition, the MEK disruptor peptide promoted the ability of betaarrestin1 to co-immunoprecipitate with endogenous c-Src and clathrin, facilitating the isoprenaline-stimulated internalization of the beta(2)-adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19153083      PMCID: PMC2670148          DOI: 10.1074/jbc.M806395200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Mitogen-activated protein kinases and asthma.

Authors:  Girolamo Pelaia; Giovanni Cuda; Alessandro Vatrella; Luca Gallelli; Michele Caraglia; Monica Marra; Alberto Abbruzzese; Mario Caputi; Rosario Maselli; Francesco S Costanzo; Serafino A Marsico
Journal:  J Cell Physiol       Date:  2005-03       Impact factor: 6.384

Review 2.  Transduction of receptor signals by beta-arrestins.

Authors:  Robert J Lefkowitz; Sudha K Shenoy
Journal:  Science       Date:  2005-04-22       Impact factor: 47.728

3.  Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding.

Authors:  Shawn K Milano; You-Me Kim; Frank P Stefano; Jeffrey L Benovic; Charles Brenner
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

Review 4.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

5.  Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors.

Authors:  Christopher J Hupfeld; Jamie L Resnik; Satoshi Ugi; Jerrold M Olefsky
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

6.  Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling.

Authors:  S Ahn; S Maudsley; L M Luttrell; R J Lefkowitz; Y Daaka
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

7.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

Authors:  L M Luttrell; S S Ferguson; Y Daaka; W E Miller; S Maudsley; G J Della Rocca; F Lin; H Kawakatsu; K Owada; D K Luttrell; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

8.  Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.

Authors:  Jeffrey F Ohren; Huifen Chen; Alexander Pavlovsky; Christopher Whitehead; Erli Zhang; Peter Kuffa; Chunhong Yan; Patrick McConnell; Cindy Spessard; Craig Banotai; W Thomas Mueller; Amy Delaney; Charles Omer; Judith Sebolt-Leopold; David T Dudley; Iris K Leung; Cathlin Flamme; Joseph Warmus; Michael Kaufman; Stephen Barrett; Haile Tecle; Charles A Hasemann
Journal:  Nat Struct Mol Biol       Date:  2004-11-14       Impact factor: 15.369

9.  RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells.

Authors:  Martin J Lynch; George S Baillie; Ahmed Mohamed; Xiang Li; Charlotte Maisonneuve; Enno Klussmann; Gino van Heeke; Miles D Houslay
Journal:  J Biol Chem       Date:  2005-07-19       Impact factor: 5.157

10.  Phosphodiesterase-4 influences the PKA phosphorylation status and membrane translocation of G-protein receptor kinase 2 (GRK2) in HEK-293beta2 cells and cardiac myocytes.

Authors:  Xiang Li; Elaine Huston; Martin J Lynch; Miles D Houslay; George S Baillie
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

View more
  38 in total

Review 1.  Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2012-06-01       Impact factor: 4.315

Review 2.  Extensive shape shifting underlies functional versatility of arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Curr Opin Cell Biol       Date:  2013-11-16       Impact factor: 8.382

3.  Coupling to Gq Signaling Is Required for Cardioprotection by an Alpha-1A-Adrenergic Receptor Agonist.

Authors:  Bat-Erdene Myagmar; Taylor Ismaili; Philip M Swigart; Anaha Raghunathan; Anthony J Baker; Sunil Sahdeo; Jonathan M Blevitt; Marcos E Milla; Paul C Simpson
Journal:  Circ Res       Date:  2019-08-20       Impact factor: 17.367

Review 4.  Plethora of functions packed into 45 kDa arrestins: biological implications and possible therapeutic strategies.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Mol Life Sci       Date:  2019-08-17       Impact factor: 9.261

Review 5.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

Review 6.  G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.

Authors:  Douglas G Tilley
Journal:  Circ Res       Date:  2011-07-08       Impact factor: 17.367

7.  A single mutation in arrestin-2 prevents ERK1/2 activation by reducing c-Raf1 binding.

Authors:  Sergio Coffa; Maya Breitman; Benjamin W Spiller; Vsevolod V Gurevich
Journal:  Biochemistry       Date:  2011-07-13       Impact factor: 3.162

Review 8.  The structural basis of the arrestin binding to GPCRs.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Mol Cell Endocrinol       Date:  2019-01-28       Impact factor: 4.102

9.  Targeting individual GPCRs with redesigned nonvisual arrestins.

Authors:  Luis E Gimenez; Sergey A Vishnivetskiy; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

10.  Therapeutic potential of small molecules and engineered proteins.

Authors:  Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.